AbbVie Inc. is challenging the Trump administration’s decision to select its Botox drug for a government program that slashes ...
By Jonathan Stempel Feb 11 (Reuters) - AbbVie sued the U.S. Department of Health and Human Services on Wednesday, challenging ...
MiBolsilloColombia on MSN
Botox under Medicare? Why the government is targeting the injectable's price
The U.S. government plans to lower Medicare costs for Botox by targeting its medical uses, marking a major shift in drug ...
President Donald Trump and the Centers for Medicare & Medicaid Services (CMS) recently announced the 15 drugs whose prices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results